Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-23

Clinical Trial Update: Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated omalizumab use and asthma-related quality of life in adults with severe persistent allergic asthma. The study results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omalizumab (Omalizumab)

Snippet

Sponsor: Novartis | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2011-05-23